International Symposium on the Evaluation of Butadiene and Chloroprene Health Risks.
These proceedings represent nearly all the platform and poster presentations given during the International Symposium on Evaluation of Butadiene and Chloroprene Health Risks, held in Charleston, South Carolina, USA, on September 20-22, 2005. The Symposium was attended by 78 participants representing private industry (37), academia (21), government (11), not-for-profit organizations (5), and consulting (4). The program followed the format of previous symposia on butadiene, chloroprene, and isoprene in London UK (2000) and butadiene and isoprene in Blaine, Washington USA (1995). This format enabled the exchange of significant new scientific results and discussion of future research needs. Isoprene was not evaluated during the 2005 Symposium because of lack of new data. For background information, the reader is referred to the proceedings of the London 2000 meeting for a thorough historical perspective and overview of scientific and regulatory issues concerning butadiene, chloroprene, and isoprene [Chem.-Biol. Interact. (2001) 135-136:1-7]. The Symposium consisted of seven sessions: (1) Introduction and Opening Remarks, (2) Butadiene/styrene-butadiene rubber (SBR)--Process Overview, Exposure and Health Effects/Human Studies; (3) Chloroprene--Process Overview, Exposure and Health Effects/Human Studies; (4) Mode of Action/Key Events; (5) Risk Assessment; (6) Poster Presentations; and (7) Panel Discussion and Future Directions. The Symposium concluded with a discussion by all participants of issues that arose throughout the course of the Symposium. The Proceedings of the Symposium published in this Special Issue are organized according to the Sessions outlined above. The purpose of this foreword is to summarize the presentations and their key findings and recommend future research directions for each chemical.
Himmelstein
Matthew W
MW
DuPont Haskell Laboratory for Health and Environmental Sciences, Newark, DE 19714, USA. matthew.w.himmelstein@usa.dupont.com
Baan
Robert A
RA
Albertini
Richard J
RJ
Bird
Michael G
MG
Lewis
R Jeffrey
RJ
D002070:Butadienes / Q000378:metabolism / Q000633:toxicity*; D002737:Chloroprene / Q000378:metabolism / Q000633:toxicity*; D004249:DNA Damage / Q000187:drug effects; D006262:Health; D006801:Humans; D018570:Risk Assessment
D002070:Butadienes; D002737:Chloroprene; C031763:1,3-butadiene